ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,782,795 | +3.4% | 426,848 | -4.1% | 1.64% | +14.1% |
| Q2 2023 | $23,962,801 | +380.5% | 445,157 | +254.5% | 1.44% | +331.7% |
| Q1 2023 | $4,987,084 | +2.3% | 125,556 | +3.6% | 0.33% | -7.7% |
| Q4 2022 | $4,875,313 | +28.0% | 121,186 | +2.3% | 0.36% | +21.1% |
| Q3 2022 | $3,809,000 | +6.4% | 118,510 | -1.8% | 0.30% | +10.3% |
| Q2 2022 | $3,579,000 | +8.1% | 120,641 | +2.4% | 0.27% | +29.7% |
| Q1 2022 | $3,311,000 | -35.1% | 117,801 | +6.4% | 0.21% | -25.1% |
| Q4 2021 | $5,103,000 | +40.4% | 110,751 | +0.0% | 0.28% | +43.8% |
| Q3 2021 | $3,634,000 | -1.2% | 110,726 | +5.5% | 0.19% | +1.0% |
| Q2 2021 | $3,678,000 | -3.4% | 104,941 | -0.4% | 0.19% | -8.6% |
| Q1 2021 | $3,808,000 | +22.8% | 105,381 | -1.3% | 0.21% | +28.0% |
| Q4 2020 | $3,102,000 | -11.9% | 106,802 | -14.4% | 0.16% | -26.8% |
| Q3 2020 | $3,520,000 | +57.2% | 124,763 | +80.2% | 0.22% | +46.4% |
| Q2 2020 | $2,239,000 | -43.4% | 69,236 | -28.7% | 0.15% | -56.0% |
| Q1 2020 | $3,956,000 | -29.0% | 97,111 | +7.5% | 0.35% | -5.2% |
| Q4 2019 | $5,571,000 | -18.4% | 90,339 | -3.5% | 0.37% | -24.9% |
| Q3 2019 | $6,826,000 | -7.9% | 93,664 | +3.9% | 0.49% | -3.2% |
| Q2 2019 | $7,410,000 | +21.4% | 90,140 | +4.2% | 0.50% | +14.5% |
| Q1 2019 | $6,103,000 | +69.8% | 86,517 | +8.3% | 0.44% | +50.5% |
| Q4 2018 | $3,595,000 | -9.4% | 79,852 | +13.7% | 0.29% | +11.8% |
| Q3 2018 | $3,970,000 | -0.9% | 70,212 | +17.0% | 0.26% | -6.4% |
| Q2 2018 | $4,008,000 | +39.9% | 60,000 | +21.9% | 0.28% | +32.1% |
| Q1 2018 | $2,865,000 | +12.6% | 49,217 | +24.6% | 0.21% | +13.4% |
| Q4 2017 | $2,545,000 | +31.4% | 39,487 | +7.0% | 0.19% | +29.0% |
| Q3 2017 | $1,937,000 | +83.1% | 36,894 | +63.1% | 0.14% | +93.3% |
| Q2 2017 | $1,058,000 | +37.6% | 22,614 | +45.6% | 0.08% | +33.9% |
| Q1 2017 | $769,000 | – | 15,530 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 348,106 | $13,826,771 | 5.10% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 206,328 | $8,195 | 2.80% |
| Global Alpha Capital Management Ltd. | 462,961 | $18,388,811 | 1.67% |
| Worth Venture Partners, LLC | 85,558 | $3,398,364 | 1.66% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $273,750 | 1.14% |
| Parkman Healthcare Partners LLC | 100,000 | $3,972,000 | 0.86% |
| MARATHON CAPITAL MANAGEMENT | 84,890 | $3,371,831 | 0.83% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 306,277 | $12,165,322 | 0.72% |
| EMERALD ADVISERS, LLC | 373,406 | $14,831,686 | 0.71% |
| Rubric Capital Management LP | 648,041 | $25,740,189 | 0.67% |